Skip to Content

Virtus LifeSci Biotech Clinical Trls ETF BBC

Medalist Rating as of | See Virtus Investment Hub

Morningstar’s Analysis BBC

Will BBC outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in Virtus LifeSci Biotech Clinical Trls ETF's Process and People Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BBC

  • Current Portfolio Date
  • Equity Holdings 112
  • Bond Holdings 0
  • Other Holdings 2
  • % Assets in Top 10 Holdings 19.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Bny Mellon Cash Reserve Usd

3.04
277,033
Cash and Equivalents
2.49
227,237
Healthcare
2.12
193,543
Healthcare
2.10
191,518
Healthcare
1.77
161,277
Healthcare
1.71
155,714
Healthcare
1.69
154,312
Healthcare
1.60
145,587
Healthcare